Black cohosh (Cimicifuga racemosa) is commonly known for its potential to help manage menopausal symptoms like hot flashes [PMID 12445983, PMID 23459142]. However, as women navigate midlife and menopause, concerns often extend beyond immediate discomforts to long-term health, including bone density and cardiovascular well-being.
This article explores the current, albeit limited, research into black cohosh’s potential effects on bone density and cardiovascular health. It’s important to understand that much of this evidence comes from preliminary studies, often in animal models, and human data is still emerging. We aim to provide a careful, evidence-based overview without overstating any findings.
Black Cohosh and Bone Density: Early Research
Maintaining bone density is a significant concern for women in menopause, as declining estrogen levels can impact bone health. Some preliminary research has explored whether black cohosh might play a role in supporting bone metabolism.
Studies in animal models have offered some insights. For instance, a 2024 study in ovariectomized rats, a model often used to simulate postmenopausal conditions, investigated the coadministration of black cohosh extract and risedronate. This research looked at the effects on bone health in these rats [1]. Similarly, another study in 2022 examined the effects of black cohosh preparations on bone metabolism in rat models with peri-menopausal symptoms induced by GnRH-a [2]. These animal studies provide early signals but do not directly translate to human effects.
While animal studies show some promise, human data is less extensive. A double-blind, placebo-controlled, and conjugated estrogens-controlled study in 2006 investigated the effects of black cohosh on bone turnover, among other parameters, in postmenopausal women. This study aimed to understand if black cohosh could influence markers related to bone health in humans [3]. The evidence regarding black cohosh and human bone density is still developing, and more robust human trials are needed to draw firm conclusions.
Exploring Black Cohosh’s Influence on Cardiovascular Health
Cardiovascular health also becomes a heightened focus for women during midlife and menopause. Estrogen plays a role in cardiovascular function, and its decline can influence various aspects of heart and blood vessel health. Researchers have begun to investigate if black cohosh might have any relevant effects.
Some research has looked at the impact of black cohosh on specific cardiovascular parameters. For example, a 2017 study explored the effects of estrogen and Cimicifuga racemosa (black cohosh) on the cardiac noradrenaline pathway in ovariectomized rats [4]. This type of research helps to understand potential mechanisms of action at a physiological level.
In human studies, a 2018 investigation focused on the effects of Cimicifuga racemosa on hemodynamic parameters and quality of life in perimenopausal women experiencing arterial hypertension. This study aimed to observe how black cohosh might influence blood pressure and overall well-being in this specific population [5]. While these findings are interesting, they represent specific aspects of cardiovascular health, and comprehensive human trials are needed to fully understand any potential broader cardiovascular implications of black cohosh.
Mechanisms and Considerations: How Black Cohosh Might Work
The way black cohosh might exert its effects, whether on bone density or cardiovascular health, is a subject of ongoing research. It is important to note that black cohosh is considered a non-estrogenic alternative for managing climacteric complaints [6]. This means its actions are thought to be different from those of estrogen itself.
One area of exploration involves its potential influence on cellular processes. For instance, a 2025 study suggested that Cimicifuga racemosa extract Ze 450 can shift macrophage immunometabolism and attenuate pro-inflammatory signaling [7]. Macrophages and inflammation are involved in various bodily processes, including those related to bone and cardiovascular health. Understanding these cellular interactions is crucial for elucidating how black cohosh might have broader effects beyond hot flashes.
The complexity of hormonal changes during aging and menopause means that natural strategies to optimize estrogen levels are of interest [8]. However, for black cohosh, its non-estrogenic nature means its potential benefits, if any, would likely stem from different pathways. Further research is needed to fully characterize these mechanisms.
Limitations and Future Directions
The current evidence regarding black cohosh’s effects on bone density and cardiovascular health is limited. Many studies are preclinical, meaning they are conducted in laboratories or on animal models, and these findings do not always directly translate to humans. While such studies provide valuable foundational insights, they are not sufficient to establish efficacy or safety for human use in these specific areas.
Human studies, where available, are often preliminary or focus on specific markers rather than long-term outcomes. For example, while a study might look at bone turnover markers, this is not the same as demonstrating a reduction in fracture risk. Similarly, observing changes in hemodynamic parameters is not equivalent to proving a reduction in cardiovascular disease events.
More extensive, well-designed, randomized controlled trials in human populations are necessary to draw more definitive conclusions about black cohosh’s potential role in supporting bone density and cardiovascular health. These studies would need to track participants over longer periods and measure clinically relevant outcomes.
References
- The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model. Frontiers in pharmacology, 2024
- A Preliminary Study on the Effects of Black Cohosh Preparations on Bone Metabolism of Rat Models With GnRH-a-Induced Peri-Menopausal Symptoms. Frontiers in endocrinology, 2022
- Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause (New York, N.Y.), 2006
- Effects of oestrogen and Cimicifuga racemosa on the cardiac noradrenaline pathway of ovariectomized rats. Experimental physiology, 2017
- Effects of cimicifuga racemosa on the hemodynamics parameters and quality of life in perimenopausal women with arterial hypertension. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2018
- The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa). The Journal of steroid biochemistry and molecular biology, 2014
- Cimicifuga racemosa extract Ze 450 shifts macrophage immunometabolism and attenuates pro-inflammatory signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025
- Natural strategies to optimize estrogen levels in aging women: mini review. Frontiers in aging, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
